Allelic exclusion at the T cell receptor et locus TCR-ot is incomplete, as demonstrated by the presence of a number of T lymphocyte clones carrying two expressed ot chain products. Such dual 0t chain T cells have been proposed to play a role in autoimmunity, for example, because of a second TCR-~x[3 pair having bypassed negative selection by virtue of low expression. We examined this hypothesis by generating mice of various autoimmunity-prone strains carrying a hemizygous targeted disruption of the TCR-cx locus, therefore unable to produce dual cx chain T cells. Normal mice have a low but significant proportion ofT cells expressing two cell-surface TCR-ot chains that could be enumerated by comparison to TCR-ot hemizygotes, which have none. Susceptibility to various autoimmune diseases was analyzed in TCR-ot hemizygotes that had been backcrossed to disease-prone strains for several generations. The incidence of experimental allergic encephalomyelitis and of lupus is not affected by the absence of dual TCR-ot cells. In contrast, nonobese diabetic (NOD) TCRot hemizygotes are significantly protected from cyclophosphamide-accelerated insulitis and diabetes. Thus, dual ot T cells may play an important role in some but not all autoimmune diseases. Furthermore, since protected and susceptible NOD mice both show strong spontaneous responses to glutamic acid decarboxylase, responses to this antigen, if necessary for diabetetogenesis, are not sufficient.
Summary
Allelic exclusion at the T cell receptor et locus TCR-ot is incomplete, as demonstrated by the presence of a number of T lymphocyte clones carrying two expressed ot chain products. Such dual 0t chain T cells have been proposed to play a role in autoimmunity, for example, because of a second TCR-~x[3 pair having bypassed negative selection by virtue of low expression. We examined this hypothesis by generating mice of various autoimmunity-prone strains carrying a hemizygous targeted disruption of the TCR-cx locus, therefore unable to produce dual cx chain T cells. Normal mice have a low but significant proportion ofT cells expressing two cell-surface TCR-ot chains that could be enumerated by comparison to TCR-ot hemizygotes, which have none. Susceptibility to various autoimmune diseases was analyzed in TCR-ot hemizygotes that had been backcrossed to disease-prone strains for several generations. The incidence of experimental allergic encephalomyelitis and of lupus is not affected by the absence of dual TCR-ot cells. In contrast, nonobese diabetic (NOD) TCRot hemizygotes are significantly protected from cyclophosphamide-accelerated insulitis and diabetes. Thus, dual ot T cells may play an important role in some but not all autoimmune diseases. Furthermore, since protected and susceptible NOD mice both show strong spontaneous responses to glutamic acid decarboxylase, responses to this antigen, if necessary for diabetetogenesis, are not sufficient.
I
t is evident from analysis ofT cell clones and TCR transgenic mice that allelic exclusion is incomplete for the TCR-o~ locus, as many T cells are found to carry two functionally rearranged products (1-3). Using human peripheral blood, it was estimated from the frequency of cells giving dual staining for two different Vet chain antibodies that ~30% of human peripheral T cells may express two functional TCR-ot chains (4) . Such findings may have important implications for autoimmune disease: any dual TCR-o~ T cell may be positively selected using one TCR-ot[3 pair, but may prove autoreactive via its second o~ combination, particularly if escape is facilitated by the second receptor being expressed at low density on emergent cells (5) . For example, in TCR transgenic mice expressing an anti-H-2K b receptor, cells expressing only the clonotypic cxl3 pair showed high TCR expression, while cells expressing two cx chains paired with the transgenic [3 chain had a lower TCR density. On crossing TCR transgenic mice with a transgenic line expressing the target antigen, only the TCR hi cells were deleted (5) .
We have explored the potential role of dual TCR-0~ T cells in autoimmune disease by backcrossing mice of several autoimmunity-prone strains onto a strain carrying a TCIL-e~ gene disrupted by homologous recombination (6) . Mice homozygous for this mutation lack o~3 TCR-bearing cells, but in the hemizygous state, they appear phenotypically and functionally normal (6, 7) , including the number and proportion ofCD3 + cells in the thymus and periphery (E1-liott, J., unpublished observations). To assess the effect of the hemizygous TCR-o~ mutation (and consequent inability to generate dual ot T cells) on type I diabetes, experimental allergic encephalitis (EAE) 1, and lupus, the mutation was bred for six or more generations onto each of the strains: nonobese diabetic (NOD), SJL, and MRL lpr/lpr.
Materials and Methods
Mice. A targeted mutation of the TCR-~x locus in 129 strain mice (6) was crossed for several generations onto NOD, SJL (CRC, Harrow, London, UK), and MRL/lpr (Olac, Bicester, UK) backgrounds. Mice carrying the targeted disruption were identified by PCR (8) . Mice crossed to the NOD, SJL, and MRL/Ipr strains were analyzed for disease incidence at six to seven backcross generations. Wild-type controls in each experiment are the negative littermates from mating of TCR-~ hemizygotes.
Genotypic Analysis. In the case of TCR-~x hemizygous mice crossed onto the NOD background, genotypic analysis was conducted to analyze the relative contributions of NOD and 129 sequences, particularly in regions near to proposed diabetes susceptibility loci. The rmcrosatellite markers used were those described previously (9) (10) (11) Ltd., Salisbury, UK) in PBS intraperitoneally. Mice were checked for signs of disease from day 11:0 = normal; I = limp tail; 2 = impaired righting reflex; 3 = partial hindlimb paralysis; 4 = complete hindlimb paralysis; 5 = moribund.
To accelerate diabetes in mice on the NOD background, TCR-~x +/+ and TCR-o~ +/-mice were injected intraperitoneally with 200 mg/kg cyclophosphamide (Asta Medica, Cambridge, UK) (a drug that, while increasing the rapidity and incidence of diabetes in the NOD mouse, does not induce insulitis or diabetes in nomlal mouse strains [13, 14] , NOD.H-2/' mice [15] , or F1 crosses of NOD with nomaal mice [14] ) twice within a 14-d interval. 28 d after the first injection, the mice were killed. Blood glucose was measured at the time of death using Glucostix (Bayer Diagnostics, Basing'stoke, UK). Mice were 6-6.5 mo old at time of death. They were housed in a non-specific pathogen-free facility, which retarded spontaneous disease by "-'3 mo compared with incidence in our specific pathogen-free unit. Hematoxylin and eosin-stained pancreas sections were scored blind for islet pathology: I = peri-islet infiltration; 2 = mild intra-islet infiltration; 3 = severe intra-islet infiltration; 4 = loss of islet architecture. Normal blood glucose was defined as being less than the mean + 2.5 SI) of readings from age-matched NOD mice carrying an H-2Eot transgene, which confers complete protection from diabetic pathology (16) .
To assess susceptibility to lupus, sixth generation backcross MRL lpr/lpr TCt<o~ +/+ and TClLci +7-mice were immunized intradermally with 0.1 ml CFA to accelerate disease (17) . Day 28 serum samples were tested for c~-dsDNA antibodies in an ELISA using $1 nuclease-treated calf thymus DNA (Sigma lmmunochemicals, St. Louis, MO) -coated plates, essentially as described elsewhere (18) . Mice were tested for hematuria on day 28, killed, and their blood was tested for uremia. Samples were assessed for hematuria using Labstix (Bayer Diagnostics) and for uremia using Azostix (Bayer Diagnostics).
T Cell Proliferation Assays. Splenocytes from untreated NOD TCR.o~+/+ or TCP,.ci +/ 12-wk-old mice were cultured in HL1 medium supplemented with antibiotics, glutamine, and 2-ME (Hycor Biomedical Inc., trvine, CA) at 4 • l0 s cells per well with 25 txg/ml recombinant rat GAD67 protein (encompassing amino acids 332-584) expressed in the pGEX1 vector or with control pGEX fusion protein (gifts from Dr. O. Birk, Weizmann Institute, R.ehovot, Israel). As an additional control for any mitogenie or nonspecific effect of the antigen preparations, responses were compared between female mice and male littermates that were only mildly susceptible to disease. Assays were cultured for 72 h, pulsed with l I.tCi [3H]thymidine per well for the final 6 h and harvested for liquid scintillation counting.
Results

Frequency of Dual TCR-oe Cells. We compared TCR-Ix
hemizygote (lacking dual o~ T cells) and wild-type littermates for the presence of T cells carrying both Vcl2 and Vix8 (Fig. 1) . To calculate the frequency of dual cx T cells in wild-type mice (Table 1) Incidence of Diabetes and Insulitis in TCR-oe Hemizygous NOD Mice. TCR-{x hemizygous of~pring were compared with wild-type littetmates for incidence of cyclophosphamide-induced diabetes. Both female and male NOD TCR-{x +/-mice were significantly protected from induction of diabetes assessed by islet infiltration (Fig. 2 ) and blood glucose (Fig. 3) . Only two male and one female TCR-{x +/-mice showed moderate islet infiltration and none displayed elevated blood glucose levels. Since it was possible that by backcrossing the homologous recombination event from chromosome 14 of the founder 129 mice onto NOD we may have selected against an NOD diabetes susceptibility locus, we conducted a PCR analysis with markers linked to the known NOD susceptibility loci (Table 2). The strongest susceptibility locus, which is within the H-2 region, is entirely NOD-derived in the nfice that were analyzed. Furthermore, Iddl I (D4Mit71), ldd7 (Cknml), and Idd4 (Grip) (19) For analysis of the NOD v 129 contribution to TCR-ot +/-(n = 18) and TCR-ct +/+ (n = 26) mice in the sixth and seventh backcross generation, PCR was used to distinguish between NOD and 129 microsatellites and H-2-specific markers* that were specific for H-2A b. decrease the overall diabetes rate, only chromosome 14 genes cosegregating with the mutant T C R -o t could potentially contribute to the relative disease susceptibility between T C R -o t hernizygous and wild-type mice at any given generation. While the fact that three T C R -o t + / -mice developed moderate insulitis indicates that protection which may be afforded by the absence of dual c~ T cells is incomplete, the results suggest that these cells may play an important role in diabetes pathogenesis.
T Cell Responses to Glutamic Acid Decarboxylase (GAD) in Protected TCR-e~ Hemizygous N O D Mice
. R e c e n t studies have investigated the islet autoantigens recognized by N O D T cells (20, 21) ; while the primary target is still unclear, GAD is a strong candidate. W e compared the spontaneous T cell response to GAD 67 of N O D mice with or without dual TCR-ct T cells (Fig. 4) , confirming that N O D mice respond spontaneously to GAD. However, strong responses were found in both groups of mice, despite the fact that the vast majority o f T C R -~ +/-mice do not develop islet pathology. The T cell response to control fusion protein in each case was in the range o f 10-15% o f the response to recombinant GAD protein: the mean response to control p G E X protein the experiment shown was 1,486 + 967. As a further control for nonspecific or mitogenic effects o f the GAD fusion protein, we analyzed the response to recombinant GAD in male N O D mice, which are less susceptible to disease and make reduced responses to a range o f islet antigens, including GAD. W e conclude that if T cell recognition of GAD is necessary for development of disease, it is not sufficient.
Incidence of EAE in Hemizygous Mutant
Mice. TCR-c~ +/-mice crossed onto an SJL background and wild-type littermates were compared for susceptibility to EAE induced by immunization with the dominant encephalitogenic epitope for this strain, PLP 139-151 (13) . N o difference was found between the two groups (Fig. 5) .
Incidence of Lupus in Hemizygous Mutant MRL lpr/Ipr
Mice. Female backcrossed T C R -0 0 / -m i c e developed similar levels o f ot-dsDNA antibodies and kidney disease to wild-type littermates (Fig. 6 ). All mice were affected, mean peak antibodies being 0.77 + 29 in T C R -o t +/-mice (absorbance at 1/50 dilution) and 0.82 + 0.32 in T C R -e O / + mice. No significant difference between antibody titers of TCR-ot +/-and TCR-(x +/+ mice was found at any point. Analysis of hematuria and uremia also revealed no significant difference between groups (data not shown).
Discussion
The finding that a substantial proportion of human peripheral blood T cells possess two cell surface TCR-~x chains and consequently two distinct TCR-o~[3 pairs has important implications for autoimmunity (4) . It has been suggested that T cells positively selected through one (x13 pair may prove autoreactive via another. We examined this hypothesis by derivation of mice from strains susceptible to autoimrnune diseases and that are hemizygous for an engineered mutation in the TCR-ot locus. Because a direct comparison can be made between FACS| staining of dual ot chain cells in normal mice and hemizygotes, the true number of cells of this type can be assessed more confidently than is possible in human peripheral blood, where a figure for the proportion of dual TCR-0~ T cells approaching 30% was derived. A caveat to the estimate in humans is that FACS| noise (i.e., events falling within the dual a chain-positive gate as a result of nonspecific staining with antibody) may have added to the apparent frequency. The use of TCR-ot hemizygous mice as a background from which to calculate FACS| noise has allowed us to show that in mice, only ~10% of peripheral T cells possess two cell-surface TCR-ix chains at detectable levels, as extrapolated from the proportion ofV{x2+er + cells.
NOD TCR-{x hemizygous mice were substantially protected from the induction of insulitis and diabetes. Importantly, such protection is not complete, as evidenced by islet infiltration in three mice in this study, as well as by the occasional occurrence of overt diabetes in TCR-ix hemizygous mice during the course of backcrossing the TCR-oe mutation (consequently outside of any controlled comparison with wild-type littermates). Protection in hemizygous mice may theoretically be the consequence of immunological changes and/or genetic changes at a NOD disease locus. According to the immunological explanation, which we consider the more likely, the dual TCR-{x T cells would have some significant role in diabetogenesis. It is implicit in the hypothesis that the dual TCR-(x T cell population is likely to harbor a disproportionately high number of autoreactive cells. Any hypothesis for the role of dual TCR-(x cells in autoreactivity must explain why dual receptors are not subject to negative selection at the same stringency as single receptors. This may result if a second receptor were expressed at low density. While our data suggest that dual TCR-(x T cells have a role in the pathogenesis of diabetes, it is clear that pathogenic T cells, either in this disease or in other autoimmune diseases, need not necessarily be of this type. Thus, in EAE and diabetes TCR transgenic models, the incidence of spontaneous disease actually increases when TCR transgenic mice are crossed onto a "knockout" background precluding the expression of endogenous ot chains (22) . Furthermore, a number of T cell clones that have been shown to transfer autoimmune disease only express a single TCR-e~ [3 pair (23) .
A more trivial explanation of protection in TCR--{x hemizygote NOD would be that it is dependent on a diabetes gene linked to the TCR-ix locus on chromosome 14 of the 129 strain. Since the study used wild-type littermates of TCR-{x hemizygote mice as the control for diabetes incidence, the two groups differ significantly only at loci on chromosome 14, and hence it is highly unlikely that the disease susceptibility difference between the two is dependent on diabetes loci on other chromosomes. It is possible, however, that contamination with unidentified regions of the 129 genome lowered the overall diabetes incidence in both groups.
The generation of NOD mice that are resistant to the development of diabetes enabled us to ask how protection correlated with the presence or absence of T cell responses to candidate islet autoantigens. A number of groups demonstrated that insulin-dependent diabetes mellitus patients analyzed early in disease make T cell responses to GAD (24) (25) (26) . The response to the two isoforms, GAD 65 and GAD 67, are among the earliest antiislet responses detectable in NOD mice, and tolerogenic immunization with either isofoml can reduce or delay the onset of disease (20, 21, 27) . We analyzed responses to GAD 67 since this is the predominant GAD isoform expressed in NOD islets (28) . Wild-type NOD mice, which are susceptible to diabetes, or their TCR-c~ hemizygous littermates, which are not, make identical responses to the GAD 67 fragment tested. This suggests that if the T cell response to GAD is indeed necessary for pathogenesis, as implied by the tolerance induction experiments, it is not sufficient. One caveat is that the fragment we used encompasses only amino acid residues, 332-584; it therefore contains most of the key epitopes that have previously described in patients or NOD mice (e.g., the 509-528 and 524-543 epitopes described by Kaufinan et al. (20) , the 550-585 fragment in Elliott et al. (27) , and a major disease-associated epitope in patients (26) . The fragment, however, lacks the 247-266 epitope recognized in some diabetes studies (20, 25) .
To conclude our report, the data we present show first that dual ci T cells are present in mice at a low frequency (,'~10%). Second, while dual 0~ T cells are not a prerequisite for autoimmune disease per se, they may strongly predispose to the induction of NOD diabetes.
